Akums and Triple Hair Group Partner to Launch Alopecia Treatment in India

Akums Drugs & Pharmaceuticals, a CDMO, has entered into a strategic partnership with Triple Hair Group, a Canadian company focusing on creating new remedies for androgenic alopecia. This is specifically for the exclusive licensing of their patented topical formulation in the Indian market. It contains three medications to treat alopecia, a widespread condition impacting millions in India and around the globe.

The recently approved topical solution aims to offer a complete approach to hair maintenance. It helps to stop hair loss, promote fresh hair growth, and increase hair fullness and thickness, providing a complete remedy for individuals dealing with hair thinning and balding. This advanced formula offers a convenient and efficient choice for users who favor topical treatments, with the possibility to enhance adherence and results for those dealing with hair loss.

This partnership is in line with our goal of providing innovative solutions that meet the changing demands of our clients. Sandeep Jain, managing director at Akums, expressed confidence that this patented formula will transform the treatment of alopecia in India, assisting numerous individuals in regaining their self-esteem and confidence.